Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc

Bullboard Posts

Comment by bfwon Jun 05, 2018 6:57am

178 Views

Post# 28124306

RE:RE:RE:Taimed's May income

Terror in the market?

Doubtful.

Perhaps in an immature market like Taiwan, one would see ”terror”.

I think it is just reflective of the ordering pattern.

bfw

Mengkung wrote: Remember from reference i checked that it indicated the payment to Taimed comes every 60-90 days ? perhaps this is just how is supposed to be so thats why CFO says " value the company with seasons instead of months ". But still this "0" is very likely to cause terror in market.

Bullboard Posts

Sony’s Alpha 1 II: A new professional photography standard?